Bevacizumab (BEV)-based therapy in the treatment of recurrent glioblastoma (GBM) in patients (PTS) treated at a Brazilian cancer center.
Rodrigo Ramella Munhoz
No relevant relationships to disclose
Maria Ignez Freitas Melro Braghiroli
No relevant relationships to disclose
Juliana Florinda De Mendonga Rego
No relevant relationships to disclose
Paulo Marcelo Hoff
No relevant relationships to disclose
Olavo Feher
No relevant relationships to disclose
Artur Katz
No relevant relationships to disclose